Table 1. Concentration of metabolites about glutathione metabolic pathways in USC cells.
Compound name | Concentration (pmol/106 cells) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
USPC-1(Control) | USPC-1(Paclitaxel) | PTX-1(Control) | PTX-1(Paclitaxel) | USPC-1(Paclitaxel) vs USPC-1(Control) | PTX-1(Paclitaxel) vs PTX-1(Control) | PTX-1(Control) vs USPC-1(Control) | PTX-1(Paclitaxel) vs USPC-1(Paclitaxel) | |||||||||
Mean | S.D. | Mean | S.D. | Mean | S.D. | Mean | S.D. | Ratio | P value | Ratio | P value | Ratio | P value | Ratio | P value | |
Folic acids | 8.5 | 4.5 | 13 | 5.2 | 13 | 3.8 | 7.1 | 3.3 | 1.5 | 0.313 | 0.5 | 0.113 | 1.5 | 0.261 | 0.5 | 0.178 |
ADP | 716 | 159 | 1,319 | 98 | 1,118 | 125 | 1,364 | 89 | 1.8 | 0.009* | 1.2 | 0.056 | 1.6 | 0.029* | 1.0 | 0.588 |
ATP | 11,072 | 5,718 | 15,846 | 651 | 10,294 | 1,417 | 9,452 | 631 | 1.4 | 0.284 | 0.9 | 0.422 | 0.9 | 0.838 | 0.6 | 2.6E-04* |
Gly | 11,954 | 4,697 | 16,374 | 245 | 16,379 | 1,012 | 15,489 | 914 | 1.4 | 0.244 | 0.9 | 0.322 | 1.4 | 0.241 | 0.9 | 0.231 |
Cys | 436 | 482 | 519 | 251 | 1,796 | 262 | 1,950 | 304 | 1.2 | 0.851 | 1.1 | 0.545 | 4.1 | 0.112 | 3.8 | 0.004* |
Glu | 64,248 | 16,387 | 83,494 | 2,271 | 75,376 | 3,081 | 65,793 | 4,357 | 1.3 | 0.177 | 0.9 | 0.041* | 1.2 | 0.360 | 0.8 | 0.008* |
Glutathione (GSSG) | 1,679 | 402 | 2,208 | 239 | 2,158 | 352 | 1,480 | 123 | 1.3 | 0.138 | 0.7 | 0.066 | 1.3 | 0.197 | 0.7 | 0.019* |
Glutathione (GSH) | 13,828 | 5,374 | 20,770 | 138 | 21,282 | 1,894 | 19,231 | 760 | 1.5 | 0.155 | 0.9 | 0.193 | 1.5 | 0.126 | 0.9 | 0.068 |
NADPH/NADP+ | N.A. | N.A. | N.A. | N.A. | N.A. | N.A. | N.A. | N.A. | N.A. | N.A. | N.A. | N.A. | N.A. | N.A. | N.A. | N.A. |
S.D.; standard deviation, ADP; adenosine diphosphate, ATP; adenosine triphosphate, NADPH; reduced nicotinamide adenine dinucleotide phosphate, NADP; nicotinamide adenine dinucleotide phosphate, *P < 0.05, N.A.; not available